Replies to post #346465 on Avid Bioservices Inc (CDMO)

[jbainseky]

That is a valid school of thought. There is at least one person with the point of view that the expansion was built and basically reserved for a specific customer(s). Timing of the build was based on anticipated (hopeful) drug approval of late-stage drugs. Thus there is no real selling other than to keep the previous capacity full.

I wouldn't even be surprised if the customer intends to buy Avid when some amount of the drugs are approved.

If your take is correct, then I agree heads need to roll. I'm just not convinced yet.

All in opinion only 😅

FFTT
JBAIN

[bfiest]

I can understand the impatience. And in my opinion what went wrong was their “current” customers were projecting “expansion supportive” increased numbers prior to the investment community rug being pulled out from the entire industry. By that point the expansion was well underway. I doubt highly that there were new customers signing promissory notes to contract with Avid upon completion of expansion. There are too many complex variables with any expansion, especially in this industry, for a potential customer to commit prior to expansion completion.

So now the investment atmosphere is becoming positive again and yes there should be no excuses for growth to be constrained. But in my opinion it’s gonna take some time. I still believe this to be a stellar investment opportunity. I anticipate the originally projected business, that led to the expansion decision, to become reality over the next year or two. And yes they need to perform! No excuses.